Story
Harvard Bioscience Stock Gains on Q2 Earnings Beat, Raised Guidance

Shares of Harvard Bioscience, Inc. (NASDAQ: HBIO) rose in trading after the company announced second-quarter financial results that exceeded market expectations and raised its full-year forecast.
Quarterly Performance Beats Expectations
For the second quarter of 2026, the Holliston, Massachusetts-based company reported revenue of $22.7 million, an increase of 11% compared to the same period last year. The company posted an adjusted loss per share of -$0.14, which was significantly better than the consensus analyst estimate of a -$0.38 loss.
Adjusted EBITDA, a key measure of profitability, improved to $1.7 million from $1.5 million in the prior-year quarter. While the net loss for the quarter widened to $2.9 million, the net loss for the first half of 2026 narrowed sharply to $6.3 million from $52.6 million a year ago, a figure that was heavily impacted by a large goodwill impairment charge in the prior period.
Upgraded Full-Year Outlook
Alongside its earnings beat, Harvard Bioscience provided an optimistic update to its financial guidance for the full year 2026. The company now anticipates:
Ad- Full-year revenue growth of 3% to 5%.
- Adjusted gross margin between 57% and 59%.
- Adjusted EBITDA growth of 6% to 10%.
For the upcoming third quarter of 2026, the company projects revenue in the range of $21.0 million to $22.6 million and adjusted EBITDA between $1.5 million and $2.5 million.
Context for Investors
The positive results and upgraded forecast suggest a strengthening recovery for the company following a difficult prior year. The performance is particularly notable given the broader headwinds facing the life sciences tools sector, including uncertainty around National Institutes of Health (NIH) funding and ongoing tariff pressures.
For investors, the combination of a substantial earnings beat, improving profitability metrics, and a raised full-year outlook provided a clear catalyst for the stock's advance. The upward revision to guidance signals management's growing confidence in its operational and financial trajectory.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.